Lineage Cell Therapeutics, Inc. Soared
Mon, May 03, 2021 at 05:30 PM
Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) soared at $78.5, a gain of 57.6%. On Fri, Apr 30, 2021, BTX:NYSEMKT hit a New 2-Week High of $49.8. The stock appeared on our News Catalysts scanner on Thu, Apr 29, 2021 at 10:01 AM in the 'BIOTECH' category. From Fri, Apr 16, 2021, the stock recorded 70.00% Up Days and 72.73% Green Days
About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)
BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.
Top 10 Gainers:
- Precipio, Inc. (PRPO:NASDAQ), 171.98%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 102.49%
- Image Sensing Systems, Inc. (ISNS:NASDAQ), 73.47%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 57.63%
- American Shared Hospital Services (AMS:NYSEMKT), 55.19%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 49.76%
- Friedman Industries, Incorporated (FRD:NYSEMKT), 24.39%
- Euroseas Ltd. (ESEA:NASDAQ), 24.31%
- Top Ships Inc. (TOPS:NASDAQ), 23.81%
- Ocugen, Inc. (OCGN:NASDAQ), 23.76%